Paul Tudor Jones Merck & Co., Inc. Put Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $1.93 Million - $2.24 Million	17,400 Added 168.93%	27,700 $3.15 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $1.28 Million - $1.37 Million	10,300 New	10,300 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $2.87 Million - $3.12 Million	28,600 Added 90.79%	60,100 $6.55 Million
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $1.31 Million - $1.45 Million	12,700 Added 67.55%	31,500 $3.24 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $141,193 - $153,894	-1,300 Reduced 6.47%	18,800 $2.17 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $2.07 Million - $2.31 Million	20,100 New	20,100 $2.14 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $1.96 Million - $2.15 Million	27,300 New	27,300 $2.05 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.